Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
---|
09/16/2008 | CA2480429C Novel therapeutical use of agonist ligands specific to g2a receptor |
09/16/2008 | CA2379557C Arylsulphonamide-substituted benzimidazole derivatives, processes for preparing them and their use as pharmaceutical compositions |
09/16/2008 | CA2346062C Coated medicament forms with controlled active substance release |
09/12/2008 | WO2008109856A2 Methods of using diazepinone compounds in treating sodium channel-mediated diseases or conditions |
09/12/2008 | WO2008109727A1 Substituted phenoxy thiazolidinediones as estrogen related receptor-alpha modulators |
09/12/2008 | WO2008109427A2 Anesthetic spray composition |
09/12/2008 | WO2008108322A2 Composition and method for protecting mitochondria |
09/12/2008 | WO2008107661A1 New methylenebisphenyl compounds useful in the treatment of inflammation |
09/12/2008 | WO2008107544A1 Derivatives of n-(heteroaryl)-1-heteroaryl-1h-indol-2-carboxamids, preparation thereof and therapeutic use thereof |
09/12/2008 | WO2008107436A1 Bicyclic organic compounds suitable for the treatment of inflammatory or allergic conditions |
09/12/2008 | WO2008106979A2 Pharmaceutical compositions comprising flavonoids and xylitol |
09/12/2008 | WO2008079257A3 Methods for treating nasal congestion in pediatric patients |
09/12/2008 | CA2680139A1 New methylenebisphenyl compounds useful in the treatment of inflammation |
09/12/2008 | CA2679944A1 Substituted phenoxy thiazolidinediones as estrogen related receptor-alpha modulators |
09/12/2008 | CA2678492A1 Bicyclic organic compounds suitable for the treatment of inflammatory or allergic conditions |
09/12/2008 | CA2670539A1 Anesthetic spray composition |
09/11/2008 | US20080221206 less anesthetic activity, but with more anti-inflammatory and spasmolytic activity; asthma, rhinitis, allergic urticaria, chronic lung inflammation associated with eosinophilia, following the example of atopic asthma and chronic intestinal inflammation, as colitis for instance |
09/11/2008 | US20080221186 4-(substituted cycloalkylmethyl) Imidazole-2-Thiones, 4-(substituted cycloalkenylmethyl) Imidazole-2-Thiones, 4-(substituted cycloalkylmethyl) Imidazol-2-Ones and 4-(substituted cycloalkenylmethyl) Imidazole-2-Ones and related compounds |
09/11/2008 | US20080221179 SUBSTITUTED PHENOXY AMINOTHIAZOLONES as estrogen related receptor-alpha modulators |
09/11/2008 | US20080221155 Novel quinuclidine derivatives and medicinal compositions containing the same |
09/11/2008 | US20080221139 Novel Compounds |
09/11/2008 | US20080221131 Respiratory system disorders; asthma; chronic obstructive pulminary disease; antiproliferative agents; immunosuppressants |
09/11/2008 | US20080221111 Combination of a Pd4 Inhibitor and a Tetrahydrobiopterin Derivative |
09/11/2008 | US20080221100 Soluble epoxide hydrolase inhibitors |
09/11/2008 | US20080221096 Pyrido[3' ,2':4,5]Furo[3,2-d]Pyrimidine Derivatives |
09/11/2008 | US20080221081 Polymorphs of 7-[(3-chloro-6,11-dihydro-6-methyldibenzo[c,f][1,2]thiazepin-11-yl)amino]heptanoic acid s,s dioxide and methods of making and using the same |
09/11/2008 | US20080221072 Fatty Acid Modified Forms of Glucocorticoids |
09/11/2008 | US20080221046 Macrolides With Anti-Inflammatory Activity |
09/11/2008 | US20080221041 Compounds with the biological activity of vasoactive intestinal peptide for the treatment of pulmonary and arteriolar hypertension |
09/11/2008 | US20080220500 Expression vector comprising nucleotide sequences coding lipogenic enzyme for treatment and prevention of cardiovascular, inflammatory, nervous system, gastrointestinal and psychological disorders |
09/11/2008 | US20080220095 Red blood cells loaded with s-nitrosothiol and uses therefor |
09/11/2008 | US20080220073 The Treatment of Respiratory Diseases |
09/11/2008 | US20080220018 administering deactivated or attenuated Streptococcus zooepidemicus, immunogenic fragment of S. zooepidemicus and/or nucleotide codes for the fragment; immunology; veterinary medicine |
09/11/2008 | US20080219997 Her-2 binding antagonists |
09/10/2008 | EP1967591A2 Method of assessing the usefulness of a test compound for alleviating a pneumococcal infection in an animal |
09/10/2008 | EP1967525A2 A method for regulating immune function in primates using the foxp3 protein |
09/10/2008 | EP1967523A1 New thiophen glycoside derivatives, method for their manufacture, medicines containing these compounds and their application |
09/10/2008 | EP1967206A2 Anti-IgE vaccines |
09/10/2008 | EP1967205A2 Anti-IgE vaccines |
09/10/2008 | EP1966200A1 Heterocyclic janus kinase 3 inhibitors |
09/10/2008 | EP1966196A2 Pure and stable tiotropium bromide |
09/10/2008 | EP1966184A2 Pyridinyl-quinazoline derivatives and their medical use |
09/10/2008 | EP1966165A1 Pyrazine derivatives as epithelial sodium channel blocker |
09/10/2008 | EP1966162A2 Pyrimidine derivatives |
09/10/2008 | EP1966156A2 New compounds iii |
09/10/2008 | EP1965792A2 Pharmaceutical compositions for the treatment of inflammatory and obstructive airways diseases |
09/10/2008 | EP1855692A4 Composition for reducing the exudation of serum proteins |
09/10/2008 | EP1427708B1 Amino-phthalazinone derivatives as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
09/10/2008 | EP1368302B1 Novel amino dicarboxylic acid derivatives |
09/10/2008 | EP1261337B1 Topoisomerase inhibitors for treatment of surgical adhesions |
09/10/2008 | EP1131356B1 Monoclonal anti alpha-D (ITGAD) antibody for use in the treatment of CNS injuries caused by trauma |
09/10/2008 | EP0771322B1 Abundant extracellular products and methods for their production and use |
09/10/2008 | CN101262880A Airway administration of tissue factor pathway inhibitor in inflammatory conditons affecting the respiratory tract |
09/10/2008 | CN101262879A Airway administration of activated protein C in inflammatory conditions affecting the respiratory tract |
09/10/2008 | CN101262872A Novel inhibitor of vascular endothelial growth factor expression |
09/10/2008 | CN101262847A Stable pharmaceutical composition comprising a pyrimidine-sulfamide |
09/10/2008 | CN101260386A Production of attenuated, human-bovine chimeric respiratory syncytial virus vaccines |
09/10/2008 | CN101260149A Streptococcus antigens |
09/10/2008 | CN101259253A Medicaments assembly for nourishing yin and clearing heat, relieving sore-throat and preparation thereof |
09/10/2008 | CN101259244A Huameiwan for treating chronic pharyngitis |
09/10/2008 | CN101259242A Medicine for treating allergic rhinitis |
09/10/2008 | CN101259217A Medicaments assembly for clearing-heat, eliminating-phlegm, clearing-lung-heat and relieving-sore-throat and preparation thereof |
09/10/2008 | CN101259211A Medicaments assembly for treating acute or chronic pharyngitis and preparation thereof |
09/10/2008 | CN101259197A Medicinal composition for treating cold and preparation thereof |
09/10/2008 | CN101259185A Yujin aerosol and preparation and use thereof |
09/10/2008 | CN101259177A Medicaments for treating chronic bronchitis and confecting method thereof |
09/10/2008 | CN101259175A Loquat flower total saponins and preparation and application thereof |
09/10/2008 | CN101259165A Chaihuang preparations and producing method thereof |
09/10/2008 | CN101259123A Application of isoforskolin and its analogue in preventing and controlling lung injury |
09/10/2008 | CN100417659C Nonsteroidal anti-inflammatory substances, compositions and methods for their use |
09/10/2008 | CN100417392C An effervescence tablet of cold-treating preparation and preparation method thereof |
09/10/2008 | CN100417383C Effervescent tablet containing cefixime and its preparing method |
09/09/2008 | US7423141 Inhibitors of endothelin-1 synthesis |
09/09/2008 | US7423067 Diphenyl cyclopentyl amides as cannabinoid-1 receptor inverse agonists |
09/09/2008 | US7423057 Dihydroorotate dehydrogenase (DHODH) inhibitors; Rheumatoid arthritis, Pneumocystis carinii, fibrosis, uveitis, rhinitis, asthma, and athropathy; 2-(Biphenyl-4-ylcarbamoyl)-cyclopent-1-enecarboxylic acid |
09/09/2008 | US7423055 e.g., 2-(2-methyl-5-amino)phenyl-4-(3-pyridyl)-thiazole; c-kit inhibitors; treating cell proliferative, metabolic, allergic, and degenerative disorders. |
09/09/2008 | US7423052 Piperidine compounds for use as orexin receptor antagoinst |
09/09/2008 | US7423049 e.g., 2-(5-fluoro-2-tolyl)-4-(4-aminocarbonylpiperazinylmethyl)-6-[a-aminocarbonyl-2,6-dichlorobenzyl]pyridine; mitogen-activated protein kinase inhibitor; antiinflammatory agent, autoimmune diseases |
09/09/2008 | US7423047 Arylamine substituted bicyclic heteroaromatic compounds as p38 kinase inhibitors |
09/09/2008 | US7423046 acetic acid (3RS,4aRS,10bRS)-6-(3,4-bis-cyclopropylmethoxyphenyl)-8,9-dimethoxy-(1,2,3,4,4a,10b)-hexahydrophenanthridin-3-yl ester, phosphodiesterase inhibitor; antiinflammatory, bronchodilator agent; bronchitis, allergic bronchitis, asthma, COPD, psoriasis, eczema, osteoarthritis, rheumatoid arthritis |
09/09/2008 | US7423041 e.g. 3-[2-(4-Aminophenyl)ethyl]-8-benzyl-1-propylxanthine; A1-adenosine receptor antagonist; antiallergen, antiinflammatory agent; AIDS and immune deficiency disorders, asthma; good water solubility |
09/09/2008 | US7422846 Detecting the activity of orphan G Protein Receptor 86 by incubating a sample comprising GPR86 and adenosine diphosphate (ADP) under binding conditions for both and detecting a second messanger; screening for a modulator |
09/09/2008 | US7422748 Combining antigen or in vivo generator with a surfactant or with a mixture of surfactants having an overall HLB number of between 5 and 15 and comprising: ethoxylated derivatives of ester of fatty acids and ethoxylated derivatives of oils |
09/09/2008 | US7422742 Gene therapy using nucleic acid molecules encoding the heavy and/or light immunoglobulin molecules; especially for treating asthma and other respiratory system disorders, administering antibody or antigen-binding fragment thereof that specifically binds IL-5 |
09/09/2008 | CA2366205C Biphenyl derivatives |
09/09/2008 | CA2346868C Sustained release pharmaceutical composition and method of releasing pharmaceutically active agent |
09/09/2008 | CA2332389C Liposomal preparations for the application of antiseptic agents to the interior of the body |
09/09/2008 | CA2323086C Regulation of endogenous gene expression in cells using zinc finger proteins |
09/04/2008 | WO2008106633A1 Methods of using benzodioxine compounds in treating sodium channel-mediated diseases or conditions |
09/04/2008 | WO2008106584A1 O-desulfated heparins treating acute exacerbations of chronic obstructive pulmonary disease |
09/04/2008 | WO2008106102A2 Inhibitors of rtp801 and their use in disease treatment |
09/04/2008 | WO2008105731A1 New use of nitrites and nitrates and compositions containing these |
09/04/2008 | WO2008105526A1 Macrocyclic compound |
09/04/2008 | WO2008105498A1 Pharmaceutical composition for ameliorating inflammation induced by il-17 |
09/04/2008 | WO2008104993A1 Use of doxycycline in the treatment of idiopathic pulmonary fibrosis |
09/04/2008 | WO2008104955A1 Azoniatricyclo [3.3.1.0] nonane derivatives as muscarinic receptor antagonists |
09/04/2008 | WO2008104869A1 Nicotinamide derivatives as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases |
09/04/2008 | WO2008104808A2 Compounds and methods for the modulation of beta-1 integrin function to mediate tissue repair |
09/04/2008 | WO2008104790A1 Salts of a selective beta-2 andrenoceptor agonist |
09/04/2008 | WO2008104752A1 Dihydropyridones as elastase inhibitors |